Skip to Content
 
Center for International Blood and Marrow Transplant Research

IB17-03b

Main Content

JAK2V617F mutation and associated chromosomal alterations in primary and secondary myelofibrosis and post-HCT outcomes.

Study #: IB17-03b

Study Status: Published

JAK2 V617F mutation and associated chromosomal alterations in primary and secondary myelofibrosis and post-HCT outcomes.

Citation

Rafati M, Brown DW, Zhou W, Jones K, Luo W, St Martin A, Wang Y, He M, Spellman SR, Wang T, Deeg HJ, Gupta V, Lee SJ, Bolon YT, Chanock SJ, Machiela MJ, Saber W, Gadalla SM.

Blood Advances. 2023, Dec 26: 7(24): 7(24):7506-7515. doi: 10.1182/bloodadvances.2023010882. Epub 2023, Oct 27. PMCID:PMC10758737.

PubMed

PMID: 38011490

Abstract